When does Sandoz report earnings and why does it matter for SDZ.SW stock?

Sandoz reports on 25 Feb 2026. The earnings release matters because guidance on biosimilars, margins and cash flow will likely move SDZ.SW stock intraday and set the tone for near-term valuation changes.

What is Meyka AI’s price forecast for SDZ.SW stock and the implied upside?

Meyka AI's yearly forecast for SDZ.SW stock is **CHF81.59**, implying an upside of **21.37%** versus the current **CHF67.22**. Forecasts are model-based projections and not guarantees.

Which valuation metrics should investors watch in the report for SDZ.SW stock?

Watch **EPS (CHF0.40)**, gross and operating margins, free cash flow conversion and the PE of **165.90**. Also compare price-to-sales (~**3.96**) and price-to-book (~**4.20**) against peers to judge re-rating risk.

How liquid is SDZ.SW stock for intraday trading?

Intraday volume today is **790,251**, above the average **740,380**, offering reasonable liquidity on SIX. Still use tight risk controls near the earnings release, as volatility can spike.

CH Stocks

SDZ.SW Sandoz at CHF67.22 on 24 Feb 2026: earnings due 25 Feb will test margins

ByDanny Kontos February 24, 2026

SDZ.SW stock is trading at CHF67.22 on 24 Feb 2026, within a day range of CHF66.30–CHF67.96 as investors position ahead of Sandoz Group AG’s earnings report due 25 Feb 2026. The group’s EPS of CHF0.40 and a high PE of 165.90 set a high bar for guidance. Today’s intraday volume is 790,251 versus an average of 740,380, signalling focused interest. We highlight the valuation gap with Swiss healthcare peers, near-term catalysts, and a Meyka AI forecast that frames upside and downside scenarios.